{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:16:59Z","timestamp":1778519819169,"version":"3.51.4"},"update-to":[{"DOI":"10.1002\/14651858.cd006044.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T00:00:00Z","timestamp":1386028800000}}],"reference-count":96,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006044.pub4","type":"journal-article","created":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T09:26:03Z","timestamp":1386062763000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Lamotrigine for chronic neuropathic pain and fibromyalgia in adults"],"prefix":"10.1002","volume":"2019","author":[{"given":"Philip J","family":"Wiffen","sequence":"first","affiliation":[{"name":"Thame UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheena","family":"Derry","sequence":"additional","affiliation":[{"name":"Oxford Oxfordshire UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"Plymouth UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,12,3]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD006044.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1212\/WNL.57.3.505","article-title":"Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study","volume":"57","author":"Eisenberg","year":"2001","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0002|cit2","first-page":"857","article-title":"Lamotrigine in the treatment of painful diabetic neuropathy: a randomized placebo controlled study","volume":"16","author":"Lurie","year":"2000","journal-title":"Progress in Pain Research and Management"},{"issue":"3","key":"10.1002\/14651858.CD006044.pub4-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0304-3959(01)00484-5","article-title":"Lamotrigine in spinal cord injury pain: a randomized controlled trial","volume":"96","author":"Finnerup","year":"2002","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0004|cit4","doi-asserted-by":"crossref","unstructured":"Jose VM Bhansali A Hota D Pandhi P Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy Diabetic Medicine 2007 377 83 10.1111\/j.1464-5491.2007.02093.x","DOI":"10.1111\/j.1464-5491.2007.02093.x"},{"issue":"1","key":"10.1002\/14651858.CD006044.pub4-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0304-3959(99)00095-0","article-title":"200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo controlled trial","volume":"83","author":"McCleane","year":"1999","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0006|cit6","doi-asserted-by":"crossref","unstructured":"Rao RD Flynn PJ Sloan JA Wong GY Novotny P Johnson DB Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3 Cancer 2008 2802 8 10.1002\/cncr.23482","DOI":"10.1002\/cncr.23482"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0007|cit7","unstructured":"NPP30010. A multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety and efficacy of lamotrigine in subjects with neuropathic pain and inadequate pain relief with gabapentin, tricyclic antidepressants or non-narcotic analgesics www.gsk-clinicalstudyregister.com\/ (Accessed 7 August 2013) 2005"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0008|cit8","doi-asserted-by":"crossref","unstructured":"Silver M Blum D Grainger J Hammer AE Quessy S Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain Journal of Pain and Symptom Management 2007 446 54 10.1016\/j.jpainsymman.2006.12.015","DOI":"10.1016\/j.jpainsymman.2006.12.015"},{"issue":"11","key":"10.1002\/14651858.CD006044.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1212\/WNL.54.11.2115","article-title":"A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy","volume":"54","author":"Simpson","year":"2000","journal-title":"Neurology"},{"issue":"9","key":"10.1002\/14651858.CD006044.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/01.WNL.0000063304.88470.D9","article-title":"Lamotrigine HIV Neuropathy Study Team. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial","volume":"60","author":"Simpson","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD006044.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1212\/WNL.56.2.184","article-title":"Lamotrigine for central poststroke pain: a randomized controlled trial","volume":"56","author":"Vestergaard","year":"2001","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0012|cit12","doi-asserted-by":"crossref","unstructured":"Vinik AI Tuchman M Safirstein B Corder C Kirby L Wilks K Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies Pain 2007 169 79 10.1016\/j.pain.2006.09.040","DOI":"10.1016\/j.pain.2006.09.040"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pain.2006.09.040","article-title":"Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies","volume":"128","author":"Vinik","year":"2007","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD006044.pub4-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0304-3959(97)00104-8","article-title":"Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial","volume":"73","author":"Zakrzewska","year":"1997","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD006044.pub4-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0039-6060(97)90129-X","article-title":"Lamotrigine reduces total postoperative analgesic requirement: a randomized double-blind, placebo-controlled pilot study","volume":"122","author":"Bonicalzi","year":"1997","journal-title":"Surgery"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0016|cit16","doi-asserted-by":"crossref","unstructured":"Breuer B Pappagallo M Knotkova H Guleyupoglu N Wallenstein S Portenoy RK A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis Clinical Therapeutics 2007 2022 30 10.1016\/j.clinthera.2007.09.023","DOI":"10.1016\/j.clinthera.2007.09.023"},{"issue":"6","key":"10.1002\/14651858.CD006044.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1046\/j.1468-1331.1998.560625.x","article-title":"Response of thalamic pain syndrome to lamotrigine","volume":"5","author":"Carrieri","year":"1998","journal-title":"European Journal of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD006044.pub4-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S0885-3924(00)00131-7","article-title":"Lamotrigine in the treatment of chronic refractory neuropathic pain","volume":"19","author":"Devulder","year":"2000","journal-title":"Journal of Pain Symptom Management"},{"issue":"8","key":"10.1002\/14651858.CD006044.pub4-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1046\/j.1365-2044.1998.00564.x","article-title":"The use of lamotrigine in neuropathic pain","volume":"53","author":"Vadi","year":"1998","journal-title":"Anaesthesia"},{"issue":"2","key":"10.1002\/14651858.CD006044.pub4-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1468-1331.1998.520167.x","article-title":"Lamotrigine in the treatment of painful diabetic neuropathy","volume":"5","author":"Eisenberg","year":"1998","journal-title":"European Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD006044.pub4-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S1090-3801(03)00020-X","article-title":"Lamotrigine for intractable sciatica: correlation between dose, plasma concentration and analgesia","volume":"7","author":"Eisenberg","year":"2003","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0022|cit22","doi-asserted-by":"crossref","unstructured":"Eisenberg E Shifrin A Krivoy N Lamotrigine for neuropathic pain Expert Review of Neurotherapeutics 2005 729 35 10.1586\/14737175.5.6.729","DOI":"10.1586\/14737175.5.6.729"},{"issue":"6","key":"10.1002\/14651858.CD006044.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1212\/WNL.48.6.1714","article-title":"Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia","volume":"48","author":"Lunardi","year":"1997","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD006044.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1526-5900(03)00718-1","article-title":"A randomized study of the effect of oral lamotrigine and hydromorphone on pain and hyperalgesia following heat\/capsaicin sensitization","volume":"4","author":"Petersen","year":"2003","journal-title":"Journal of Pain"},{"issue":"10","key":"10.1002\/14651858.CD006044.pub4-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1034\/j.1399-6576.2002.461014.x","article-title":"Lamotrigine monotherapy for control of neuralgia after nerve section","volume":"46","author":"Sandner-Kiesling","year":"2002","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD006044.pub4-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jcma.2011.04.002","article-title":"Lamotrigine for trigeminal neuralgia: efficacy and safety in comparison with carbamazepine","volume":"74","author":"Shaikh","year":"2011","journal-title":"Journal of the Chinese Medical Association"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD006044.pub4-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.pain.2010.11.010","article-title":"Pain and the brain: specificity and plasticity of the brain in clinical chronic pain","volume":"152","author":"Apkarian","year":"2011","journal-title":"Pain"},{"issue":"9","key":"10.1002\/14651858.CD006044.pub4-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0029|cit29","unstructured":"PaPaS author and referee guidance papas.cochrane.org\/papas-documents (accessed 1 August 2013)"},{"issue":"5","key":"10.1002\/14651858.CD006044.pub4-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009485.pub2","article-title":"Phenytoin for neuropathic pain and fibromyalgia in adults","author":"Birse","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD006044.pub4-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"issue":"6977","key":"10.1002\/14651858.CD006044.pub4-BIB0032|cit32","first-page":"452","article-title":"The number needed to treat: a clinically useful measure of treatment effect","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ 1995;310"},{"issue":"5","key":"10.1002\/14651858.CD006044.pub4-BIB0033|cit33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009486.pub2","article-title":"Clonazepam for neuropathic pain and fibromyalgia in adults","author":"Corrigan","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD006044.pub4-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010111","article-title":"Topical capsaicin (low concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD006044.pub4-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007393.pub3","article-title":"Topical capsaicin (high concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD006044.pub4-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"The Journal of Pain"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","article-title":"Recommendations for the pharmacological management of neuropathic pain: an overview and literature update","volume":"85(3 Suppl)","author":"Dworkin","year":"2010","journal-title":"Mayo Clinic Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD006044.pub4-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"10","key":"10.1002\/14651858.CD006044.pub4-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1517\/14656566.3.10.1411","article-title":"Anticonvulsants in central pain","volume":"3","author":"Finnerup","year":"2002","journal-title":"Expert Opinions in Pharmacotherapy"},{"issue":"10","key":"10.1002\/14651858.CD006044.pub4-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009183.pub2","article-title":"Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults","author":"Gill","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006044.pub4-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1399-6576.2007.01486.x","article-title":"Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey","volume":"52","author":"Gustorff","year":"2008","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2296-9-26","article-title":"Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005","volume":"9","author":"Hall","year":"2008","journal-title":"BMC Family Practice"},{"issue":"2","key":"10.1002\/14651858.CD006044.pub4-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009318.pub2","article-title":"Lacosamide for neuropathic pain and fibromyalgia in adults","author":"Hearn","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7414","key":"10.1002\/14651858.CD006044.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0045|cit45","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD006044.pub4-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1528-1167.2006.00423.x","article-title":"Predictors of lamotrigine-associated rash","volume":"47","author":"Hirsch","year":"2006","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD006044.pub4-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"Suppl A","key":"10.1002\/14651858.CD006044.pub4-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1053\/eujp.2001.0324","article-title":"Anticonvulsants in neuropathic pain: rationale and clinical evidence","volume":"6","author":"Jensen","year":"2002","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0049|cit49","doi-asserted-by":"crossref","unstructured":"Jensen TS Baron R Haanp\u00e4\u00e4 M Kalso E Loeser JD Rice AS A new definition of neuropathic pain Pain 2011 2204 5 10.1016\/j.pain.2011.06.017","DOI":"10.1016\/j.pain.2011.06.017"},{"issue":"5-6","key":"10.1002\/14651858.CD006044.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000110284","article-title":"Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota,1945-1984","volume":"10","author":"Katusic","year":"1991","journal-title":"Neuroepidemiology"},{"issue":"10","key":"10.1002\/14651858.CD006044.pub4-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004846.pub2","article-title":"Topical lidocaine for the treatment of postherpetic neuralgia [withdrawn]","author":"Khaliq","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD006044.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archinte.1996.00440060089011","article-title":"The importance of quality of primary studies in producing unbiased systematic reviews","volume":"156","author":"Khan","year":"1996","journal-title":"Archives of Internal Medicine"},{"issue":"1-3","key":"10.1002\/14651858.CD006044.pub4-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.pain.2009.08.023","article-title":"Incidence of facial pain in the general population","volume":"147","author":"Koopman","year":"2009","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2377-11-55","article-title":"Fibromyalgia and neuropathic pain\uff0ddifferences and similarities: a comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia","volume":"11","author":"Koroschetz","year":"2011","journal-title":"BMC Neurology"},{"issue":"2","key":"10.1002\/14651858.CD006044.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006044.pub4-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub2","article-title":"Duloxetine for treating painful neuropathy or chronic pain","author":"Lunn","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00002508-200012000-00008","article-title":"Lamotrigine in the management of neuropathic pain","volume":"16","author":"McCleane","year":"2000","journal-title":"The Clinical Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD006044.pub4-BIB0058|cit58","first-page":"9","article-title":"The epidemiology of self-reported fibromyalgia in Canada","volume":"27","author":"McNally","year":"2006","journal-title":"Chronic Diseases in Canada"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0059|cit59","volume-title":"An evidence-based resource for pain relief","author":"McQuay","year":"1998"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0060|cit60","article-title":"Chronic Pain","volume-title":"Health Care Needs Assessment","author":"McQuay","year":"2007"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006044.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/j.neuroimage.2007.03.054","article-title":"Brain imaging of neuropathic pain","volume":"37","author":"Moisset","year":"2007","journal-title":"Neuroimaging"},{"issue":"3","key":"10.1002\/14651858.CD006044.pub4-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD006044.pub4-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"April 12","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"Online","author":"Moore","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD006044.pub4-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain--establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD006044.pub4-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.pain.2010.02.032","article-title":"Topical review: chronic low back pain analgesic studies - a methodological minefield","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD006044.pub4-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD006044.pub4-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD006044.pub4-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub2","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD006044.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD006044.pub4-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"12","key":"10.1002\/14651858.CD006044.pub4-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008242.pub2","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD006044.pub4-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"Epub ahead of p","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"March 6","author":"Moore","year":"2013","journal-title":"Pain Practice"},{"issue":"4","key":"10.1002\/14651858.CD006044.pub4-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs\uff0d'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0076|cit76","unstructured":"NICE clinical guideline 173. Neuropathic pain - pharmacological management www.nice.org.uk\/guidance\/CG173 (accessed 26 November 2013) 2013 1 138"},{"issue":"1","key":"10.1002\/14651858.CD006044.pub4-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"issue":"12","key":"10.1002\/14651858.CD006044.pub4-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"e14433","DOI":"10.1371\/journal.pone.0014433","article-title":"Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials","volume":"5","author":"Phillips","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1002\/14651858.CD006044.pub4-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0304-3959(94)90086-8","article-title":"Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion","volume":"56","author":"Rappaport","year":"1994","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0080|cit80","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"Epub ahead of p","DOI":"10.1002\/art.37962","article-title":"Neuropathic features of joint pain: a community-based study","volume":"April 1","author":"Soni","year":"2013","journal-title":"Arthritis & Rheumatism"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0082|cit82","unstructured":"Summary of product characteristics for Lamictal. Section 4.8 www.medicines.org.uk"},{"issue":"2","key":"10.1002\/14651858.CD006044.pub4-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200.x","article-title":"Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia--responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"issue":"4","key":"10.1002\/14651858.CD006044.pub4-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jpain.2005.11.008","article-title":"The epidemiology of chronic pain of predominantly neuropathic origin: results from a general population survey","volume":"7","author":"Torrance","year":"2006","journal-title":"Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD006044.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrneurol.2011.4","article-title":"Can neuroimaging studies identify pain endophenotypes in humans?","volume":"7","author":"Tracey","year":"2011","journal-title":"Nature Reviews Neurology"},{"issue":"18","key":"10.1002\/14651858.CD006044.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD006044.pub4-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005451.pub2","article-title":"Carbamazepine for acute and chronic pain in adults","author":"Wiffen","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD006044.pub4-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010567","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD006044.pub4-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008314.pub3","article-title":"Topiramate for neuropathic pain and fibromyalgia in adults","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD006044.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD006044.pub4-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD006044.pub4-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"Epub ahead of p","DOI":"10.1124\/jpet.110.171108","article-title":"The anticonvulsive drug lamotrigine blocks neuronal{alpha}4{beta}2-nicotinic acetylcholine receptors","volume":"Aug 5","author":"Zheng","year":"2010","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD006044.pub4-BIB0095|cit95","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006044.pub2","article-title":"Lamotrigine for acute and chronic pain","author":"Wiffen","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD006044.pub4-BIB0096|cit96","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006044.pub3","article-title":"Lamotrigine for acute and chronic pain","author":"Wiffen","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006044.pub4\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T09:41:49Z","timestamp":1679305309000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006044.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,3]]},"references-count":96,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006044.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,3]]}}}